Additional file 4 of Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004–2024)
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
Supplementary Material Table S4: Results of a more detailed TTO analysis performed at both SOC and PT level. Min: minimum; Max: maximum; IQR: interquartile range; Q1: first quartile; Q3: third quartile; SD: standard deviation; SE: standard error.
创建时间：
2025-04-22
